Inactive Instrument

SHL Telemedicine Ltd. Stock CBOE EUROPE EQUITIES

Equities

0QMX

IL0010855885

Healthcare Facilities & Services

End-of-day quote CBOE EUROPE EQUITIES
- CHF - Intraday chart for SHL Telemedicine Ltd.
Sales 2024 * 62M 56.62M Sales 2025 * 75M 68.49M Capitalization 90.39M 82.55M
Net income 2024 * -4M -3.65M Net income 2025 * - 0 EV / Sales 2024 * 1.46 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.21 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.95%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 18-11-30
Director of Finance/CFO 58 21-12-31
Chief Operating Officer - 17-04-20
Members of the board TitleAgeSince
Director/Board Member 63 17-06-27
Chief Executive Officer 63 99-12-31
Director/Board Member - 18-12-09
More insiders
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
More about the company